Two newly identified gene variants linked to breast cancer may aid in predicting disease risk and targeting screening and prevention strategies.

When O.T. Hayes, 67, of Lebanon, Tenn., first starting seeing his cardiologist, David Hansen, M.D., for treatment of his coronary artery disease, it was hard to predict which of the various medications available would help control Haynes’ high cholesterol.

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

Vanderbilt researchers are investigating the potential benefits of prospective genetic testing for drug safety.

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.